Please provide your email address to receive an email when new articles are posted on . Kidneys from older donors showed no significant association with increased risk for delayed graft function, ...
Machine perfusion of kidneys from brain-dead donors is currently performed in approximately a third of all kidneys considered for transplantation in the United States. Machine perfusion of kidneys ...
Please provide your email address to receive an email when new articles are posted on . Patients who had delayed kidney graft function after a simultaneous heart and kidney transplant had worse ...
Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators. Dexmedetomidine may reduce the odds of delayed graft function following ...
May 8, 2007 (San Francisco) — Results of a phase II trial presented at the American Transplant Congress suggest that an experimental drug, YSPSL, could prevent delayed graft function in transplanted ...
LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback